Feasibility of Hormones and Radiation for Intermediate or High Risk Prostate Cancer
NCT01342367
·
clinicaltrials.gov ↗
NA
Phase
ACTIVE_NOT_RECRUITING
Status
74
Enrollment
OTHER
Sponsor class
Conditions
Prostate Cancer
Interventions
DRUG:
Bicalutamide
DRUG:
Dutasteride
DRUG:
Finasteride
RADIATION:
Radiation
Sponsor
University of Chicago